SeaStar Medical Holding Corporation (ICU)
- Previous Close
0.4030 - Open
0.3884 - Bid 0.2786 x 200
- Ask 0.3933 x 400
- Day's Range
0.3817 - 0.3999 - 52 Week Range
0.1620 - 1.7170 - Volume
1,192,312 - Avg. Volume
4,520,868 - Market Cap (intraday)
29.068M - Beta (5Y Monthly) -0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2100 - Earnings Date May 14, 2024 - May 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
www.seastarmedical.comRecent News: ICU
Performance Overview: ICU
Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICU
Valuation Measures
Market Cap
29.07M
Enterprise Value
37.97M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-267.33%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-26.23M
Diluted EPS (ttm)
-1.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
176k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-14.78M
Research Analysis: ICU
Company Insights: ICU
ICU does not have Company Insights